This experimental data is supported by human patient data showing that YAP or TAZ expression or nuclear localization is increased in metastatic tumors when compared to primary tumors in pancreatic cancer [87], breast cancer [86,139], and prostate cancer [140]. This evidence concerns the gene YAP1 and pancreatic neoplasm.